The Hospital Anxiety and Depression Scale (HADS) measures symptoms of anxiety and depression in individuals with MS. It consists of 14 self-reported items, with 7 items assessing anxiety and 7 items assessing depression over the past week.

Each item is rated on a 4-point Likert scale (0-3), with total scores ranging from 0 to 21 for anxiety and 0 to 21 for depression.

Interpreting the Score:

0-7: Normal (no significant symptoms) 8-10: Borderline anxiety or depression 11-21: Clinical levels of anxiety or depression Higher scores indicate greater severity of anxiety and/or depression symptoms. The HADS is widely used in clinical and research settings to assess emotional well-being in individuals with chronic conditions like MS.

The Mini-COPE (MS-Specific Brief COPE) measures coping strategies used in response to stress. The scale assesses problem-focused coping, emotion-focused coping, and maladaptive coping. It consists of 28 self-reported items, each rated on a 4-point

Likert scale:

0 = I hardly ever do this

1. = I rarely do this
2. = I do this often
3. = I almost always do this

Interpreting the Score:

• Higher scores indicate more frequent use of a specific coping strategy.
• Individual scores provide insight into which coping mechanisms are most commonly used in response to stress.

The Mini-COPE is widely used in MS research to understand coping behaviors and their impact on psychological well-being.

The Motivation for Cognition (MFC) Scale measures an individual's motivation to engage in cognitive tasks at a given moment. It consists of 10 self-reported items, each rated on a 7-point Likert scale:

• 3 = Very strongly does not apply to me

• 2 = Strongly does not apply to me

• 1 = Somewhat does not apply to me 0 = Neutral

  • 1 = Somewhat applies to me
  • 2 = Strongly applies to me
  • 3 = Very strongly applies to me

Interpreting the Score:

• Higher scores indicate greater motivation for engaging in cognitive tasks.
• Lower scores suggest reduced interest in or avoidance of cognitively demanding activities.

The MFC Scale will be used to evaluate fluctuations in cognitive motivation over time, particularly in relation to MS symptoms and menstrual cycle phases.

The SymptoMSScreen measures the impact of MS symptoms on daily life and the accommodations individuals make due to these symptoms. The scale evaluates walking, hand function, spasticity, pain, sensory symptoms, bladder control, fatigue, vision, dizziness, cognition, depression, and anxiety. It consists of 12 self-reported items, each rated on a 7-point Likert scale:

0 = No effect at all

1. = Very mild limitation
2. = Mild limitation
3. = Moderate limitation
4. = Severe limitation
5. = Very severe limitation
6. = Total limitation

Interpreting the Score:

- Higher scores indicate greater MS-related disability and symptom burden.

The SymptoMSScreen is used in MS research to assess symptom severity and it's impact on daily functioning. It's use will help track symptom progression and variability across menstrual cycle phases.

The Multiple Sclerosis Neuropsychological Screening Questionnaire - Patient Version (MSNQ) assesses cognitive and emotional difficulties in individuals with MS. The scale assesses attention, memory, problem-solving, impulse control, and emotional regulation. It consists of 15 self-reported items, each rated on a 5-point Likert scale based on frequency and severity over the past three months:

0 = Never, does not occur

1. = Very rarely, no problem
2. = Occasionally, seldom a problem
3. = Quite often, interferes with life
4. = Very often, very disruptive

Interpreting the Score:

- Higher scores indicate greater cognitive and emotional impairment related to MS.

The MSNQ is commonly used in MS research to identify cognitive difficulties and their impact on daily life. The use of MSNQ will help track cognitive fluctuations across menstrual cycle phases.